News

Executives and subject matter experts to present best practices, case studies and novel solutions for clinical trial efficiency and eConsent at Avoca, Proventa, Swiss Biotech Day, Patient-led Clinical Trials and PCMG

Philadelphia, PA and London, UK – DrugDev executives and subject matter experts will share best practices for transforming clinical trials through collaboration, standardization, and a beautiful technology experience at premier upcoming European pharma and biotech industry events over the next two months.

Avoca Quality Consortium 2017 Europe Summit (7-8 June | Dublin, Ireland)

Ibraheem “Ibs” Mahmood, DrugDev President and CEO will lead an interactive discussion on “Moving toward Greater Efficiency and Transformation in Clinical Trial Execution – What is Holding Us Back?”

Proventa Clinical Operations Strategy Meeting Europe 2017 (13 June | London, UK)

Eric Delente, President of DrugDev Patient Solutions and a foremost pioneer in electronic informed patient consent, will lead the roundtable, “Why is eConsent Important: What Are the Challenges and Barriers to Adoption?”  The roundtable will feature several essential discussion topics:

• Who benefits most from eConsent?
• How do cognitive learning techniques help in the consent process?
• What are the IRB’s responsibilities in the eIC process?
• What are the positions of Health Authorities regarding eConsent?

Clinical operations professionals may also connect with DrugDev at additional European meetings:

• Swiss Biotech Day (4 May | Basel, Switzerland)
• Patient-led Clinical Trials 2017 (8-9 May | London, UK)
• Pharma Contract Management Group (PCMG) (7-9 June | Copenhagen, Denmark)

Not attending any of these events? Visit drugdev.com or email solutions@drugdev.com to begin a conversation or schedule a demo of DrugDev Spark, the world’s first unified clinical operations suite, for your team.

About DrugDev

DrugDev helps the world do more clinical trials through industry-wide collaboration, standardization and a beautiful technology experience. The DrugDev Spark™ unified clinical operations suite is comprised of proven solutions used by 85 sponsors and CROs to transform the quality and efficiency of nearly 2,000 clinical trials from startup through closeout. DrugDev Spark is powered by the DrugDev Golden Number, the award-winning universal identifier for global site facilities and investigators used by TransCelerate and the Investigator Databank. Learn why the world’s most innovative pharma and biotech companies and CROs trust DrugDev by scheduling a demo of DrugDev Spark at drugdev.com.